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Malaria is currently a public health concern in many countries in the world due to various factors which are not
yet under check. Drug discovery projects targeting malaria often resort to natural sources in the search for lead
compounds. A survey of the literature has led to a summary of the major findings regarding plant-derived
compounds from African flora, which have shown anti-malarial/antiplasmodial activities, tested by in vitro and
in vivo assays. Considerations have been given to compounds with activities ranging from “very active” to
“weakly active”, leading to >500 chemical structures, mainly alkaloids, terpenoids, flavonoids, coumarins, phenolics,
polyacetylenes, xanthones, quinones, steroids and lignans. However, only the compounds that showed anti-malarial
activity, from “very active” to “moderately active”, are discussed in this review.
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Malaria is caused by protozoans of the genus Plasmo-
dium (Plasmodium falciparum, Plasmodium malariae,
Plasmodium ovale, and Plasmodium vivax) [1,2]. Ac-
cording to the World Health Organization (WHO), about
half of the world’s population is at risk of malaria and one
to two million annual deaths (mostly among African
children) can be attributed to malaria alone [3,4]. The
causative agent is transmitted by the female Anopheles
mosquito species, which has also developed resistance
against insecticides, such as dichlorodiphenyltrichloro-
ethane (DDT), and chemoprophylaxis has not often
yielded the expected results [2]. Additionally, the disease-
causing protozoans have developed resistance against
most of the drugs currently used to treat malaria. There is
an urgent need to discover new active compounds.* Correspondence: lmbazze@yahoo.fr
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unless otherwise stated.Nature, and particularly plants are a potential source
of new anti-malarial drugs, since they contain a quantity
of metabolites with a great variety of structures and
pharmacological activities. Traditional preparations (with
the use of macerations, extracts, steam baths, concoc-
tions, and decoctions from plant materials) have been
the main source of treatment of malaria in Africa [5]
and other continents where the disease is endemic [6,7].
Thus, with failing treatment regimens, many research
groups in Africa (African indigenous research groups
and their foreign collaborators) have resorted to plant
sources in the quest to expand the anti-malarial chemo-
therapeutic arsenal [1,8,9]. This effort has been motivated
by the use of these plant materials in the treatment of mal-
aria and fevers in African traditional medicine (ATM).
The results from Africa and other continents have been
quite promising and hence there has been a general call
for the use of natural products as drugs or as sources of
inspiration for the development of novel anti-malarials, in
order to possibly avoid problems related to drug resistance
[10-12].ral Ltd. This is an Open Access article distributed under the terms of the Creative
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the scaffolds necessary for their synthesis may be found
in the plants currently used in ATM [13,14]. However,
the last review on anti-malarial compounds from African
flora dates back about ten years [13], with other reviews
focusing on plant-screening campaigns in particular re-
gions and/or countries in Africa [15-35] or on active
compounds obtained by bioassay-guided fractionation
efforts from given countries and/or regions, not covering
an entire continent [36-41]. Even though natural prod-
ucts that are active against P. falciparum have been dis-
cussed in a number of review papers [1,42-48], the goal
has been to provide an coverage of the most promising
anti-malarials from the entire African continent, by giv-
ing an overview of the most pertinent in vitro and
in vivo screening results reported in the literature. The
most successful anti-malarials in use to date have been
derived from natural product sources (quinolones/arte-
misinins). It is indeed a glaring omission that the African
continent, despite its rich ethno-pharmocological heri-
tage, is yet to yield a significant contribution in this re-
spect. Clearly, as a first step, a systematic review of the
many traditional therapeutic options is needed and this
review addresses an important issue in this aspect. In
part I, the most promising alkaloids and terpenoids were
presented [49], while in this part the most interesting
findings for flavonoids, coumarins, phenolics, polyacety-
lates, xanthones, quinones, steroids, and lignans are
shown. The last part of the work is essentially focused
on the cheminformatic analysis of >500 natural products
(NPs), derived from African medicinal plants, which
have demonstrated from weak to very good in vitro
anti-malarial activities, with a focus on molecular
descriptors related to “drug-likeness”, drug metabolism
and pharmacokinetics (DMPK). The predicted properties
of plant-derived anti-malarials are those related to drug
absorption, distribution, metabolism, elimination, and
toxicity (ADMET) based on in silico computed molecu-
lar descriptors.Promising anti-malarial agents derived from African flora
By convention, activities were categorised into “very po-
tent”, “good”, “good to moderate”, “weak”, “very weak”
and “inactive”. Following criteria used by Mahmoudi
et al. [50] and Wilcox et al. [51], a pure compound was
considered highly active if IC50 < 0.06 μM, being active
with 0.06 μM ≤ IC50 ≤ 5 μM, weakly active when 5 μM ≤
IC50 ≤ 10 μM and compounds with IC50 > 10 μM were
considered inactive. The following inhibition percentages
were proposed for in vivo activity of antimalarial extracts
at a fixed dose of 250 mg kg−1 day−1: 100-90% (very
good activity); 90-50% (good to moderate); 50-10%
(moderate to weak); 0% (inactive) [52].Flavonoids
Several bioactive flavonoids have been derived from me-
dicinal plants growing in Africa. Even though the mo-
lecular mechanism of action of anti-malarial activities
of flavonoids is not fully elucidated, it is believed that
flavonoids act by inhibiting the fatty acid biosynthesis
(FAS II) of the parasite [53,54]. Some flavonoids have
also been shown to inhibit the influx of L-glutamine and
myoinositol into infected erythrocytes [55]. The active
anti-malarial flavonoids are summarized in Table 1,
while the chemical structures are shown in Figures 1, 2
and 3.
Chalcones
Several anti-malarial flavonoids have been isolated from
the stem bark of Erythrina abyssinica by Yenesew et al.
[56,57]. These include chalcones, prenylated and non-
prenylated isoflavones and flavones, pterocarpenes, and
flavenes. All compounds exhibited moderate anti-malarial
activity against the D6 and W2 strains of P. falciparum.
The ethyl acetate extract of the stem bark of this plant
showed anti-plasmodial activity against the chloroquine-
sensitive (D6) and chloroquine-resistant (W2) strains of
P. falciparum with IC50 values of 7.9 and 5.3 μg mL
−1,
respectively. From this extract, a new chalcone, 2′,3,4,4′-
tetrahydroxy-5-prenylchalcone or 5-prenylbutein (1), a
new flavanone, 4′,7-dihydroxy-3′-methoxy-5′-prenylflava-
none (trivial name, 5- deoxyabyssinin II) and homobutein
(2), along with known flavonoids have been isolated as the
antiplasmodial principles. Yenesew et al. also investigated
the stem bark of Milletia usaramensis ssp. usaramensis
(Leguminosae) from Kenya [58]. The chalcone 4′-O-gera-
nylisoquiritigenin (3) was isolated. This compound exhib-
ited moderate to weak antiplasmodial activity against the
D6 and W2 strains of P. falciparum. Nkunya et al. investi-
gated several Tanzanian species of the genus Uvaria [59].
Petroleum ether, dichloromethane and methanol extracts
of leaves, stem, and root bark of nine Uvaria species:
Uvaria dependens, Uvaria faulknerae, Uvaria kirkii,
Uvaria leptocladon, Uvaria lucida ssp. lucida, Uvaria sp.
(Pande), Uvaria scheffleri, and Uvaria tanzaniae were
tested for their in vitro activity against the multidrug-
resistant K-l strain of P. falciparum. The IC50 values of the
extracts varied between 5 and 500 μg mL−1. The most ac-
tive extracts were obtained from the stem and root bark of
U. lucida ssp. lucida and Uvaria sp. (Pande) and the root
bark of U. scheffleri, all of which had IC50 values between
5 and 9 μg mL−1. The investigations of these authors
yielded five important chalcones, uvaretin (4), diuvaretin
(5), triuvaretin, isotriuvaretin and chamuvaretin (6). These
compounds showed moderate to high antiplasmodial ac-
tivity against the multidrug-resistant K-1 strain of P. fal-
ciparum, with respective IC50 values of 3.49, 4.20, 46.02,
20.85 and 5.32 μg mL−1. Joseph et al. also isolated two
Table 1 Summary of promising anti-malarial flavonoids derived from African flora
Compound subclass Isolated metabolites Plant species (Family) Part of plant studied Place of harvest
(locality, country)
Author, reference
Chalcones 1 and 2 Erythrina abyssinica (Leguminosae) Stem bark Thika town, Kenya Yenesew et al. [56,57]
3 Milletia usaramensis ssp. usaramensis (Leguminosae) Stem bark Jadini Forest, Kenya Yenesew et al. [58]
4, 5 and 6 Uvaria sp. (Annonaceae) Leaves, stem and root bark Tanzania Nkunya et al. [59]
7 and 8 Friesodielsia obovata (Annonaceae) Root bark Tabora district, Tanzania Joseph et al. [60]
9, 10, 11, 12, 13, and 14 Polygonum senegalense (Polygonaceae) Aerial parts Nairobi, Kenya Midowo et al. [61]
4 and 15 Uvaria puguensis (Annonaceae) Stem bark Pugu Forest Reserve, Tanzania Makangara et al. [62]
16, 17, 18, and 19 Dorstenia barteri (Moraceae) Twigs Tombel, Cameroon Ngameni et al. [63]
Flavanones 20, 21, 22, 23, 24, and 25 Erythrina abyssinica (Leguminosae) Stem bark Thika town, Kenya Yenesew et al. [56,57]
26 and 27 Derris trifoliate (Leguminosae) Seed pods Coast Province, Kenya Yenesew et al. [64]
28 and 29 Polygonum senegalense (Polygonaceae) Aerial parts Nairobi, Kenya Midowo et al. [61]
30 Erythrina abyssinica (Leguminosae) Stem bark Thika town, Kenya Yenesew et al. [57]
31 and 32 Morus mesozygia (Moraceae) Stem bark Centre Province, Cameroon Zelefack et al. [65]
Isoflavones 33 Ficus mucuso (Moraceae) Figs Tongolo-Yaoundé, Cameroon Bankeu et al. [66]
34 Erythrina sacleuxii (Leguminosae) Root bark Kenya Andayi et al. [67]
Retonoids 35, 36, 37 and 38 Milletia usaramensis ssp.
usaramensis (Leguminosae)
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Figure 1 Promising anti-malarial chalcones derived from African flora.
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chalcone (7) and 3′,5′-dimethyl-2′,4′,6′-trihydroxy-
chalcone (8) from the root bark of Friesodielsia obovata
[60]. These two compounds exhibited moderate anti-
plasmodial activity against the K-1 strain of P. falciparum,
with respective IC50 values of 23 and 9.7 μg mL
−1. The
same trend of activity was observed against the NF54
strain, against which the compounds had IC50 values of
29 and 8.5 μg mL−1 respectively.
The new homoisoflavonoid, 5,7-dihydroxy-3-(hydroxy-
phenyl-methyl)-6-methoxy-chroman-4-one or polygoho-
moisoflavanone (9) was isolated from the aerial exudates
of Polygonum senegalense, along with the known chal-
cones 10 to 14, by Midowo et al. [61]. The newcompound, along with other components of the aerial
exudate showed good antiplasmodial activities towards
D6 and W2 strains of P. falciparum. Mukaranga et al.
investigated the stem bark of Uvaria puguensis (Anno-
naceae) from Tanzania [62]. Repeated chromatography
of the petroleum ether and chloroform extracts yielded
uvaretin (4) and the new phenanthrenoid 6-hydroxy-3-
methoxy-4-oxapyren-5-one (15), which has been named
puguenolide.
The chalcones bartericin A (16), and 4-hydroxylonch-
ocarpin (17), stipulin (18) and kanzonol B (19) were iso-
lated from the twigs of Dorstenia barteri (Moraceae)
from Cameroon by Ngameni et al. [63]. These com-
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Figure 2 Flavanones and isoflavonoid with anti-plasmodial activity, derived from plants used in African traditional medicine.
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http://www.malariajournal.com/content/13/1/81of P. falciparum. The evaluated compounds were found
to be active in vitro against P. falciparum, 16, 17 and
18, demonstrating particular potencies with relatively
low IC50 values (2.15 μM, 3.36 μM and 5.13 μM
respectively). The observed activities confirmed the
chalcones as potential leads for the development of
anti-malarials.
Flavanones
The flavanones 5-deoxyabyssinin II (20), abyssinone IV
(21), abyssinone V (22), sigmoidins A (23), B (24) and E
(25), as well as 5-deoxyabyssinin II (30) were isolated
from the stem bark of Erythrina abyssinica (Legumino-
sae), harvested in Kenya [57]. The investigations of
Yenesew et al. demonstrated that these compoundsexhibited anti-malarial properties against the W2 and
D6 strains of P. falciparum with IC50 values varying
from 4.9 to 13.6 μM against the latter strain and from
5.9 to 13.3 μM against the former strain [56,57]. The
same authors investigated the seed pods of Derris trifoli-
ate (Leguminosae) [64]. From the dichloromethane-
methanol (1:1) extract, a new flavanone derivative
(S)-lupinifolin 4′-methyl ether (26) was isolated, in
addition to the known flavonoids lupinifolin (27) and
rotenone. Lupinfolin only showed moderate in vitro
antiplasmodial activity against the D6 and W2 strains
of P. falciparum. The different parts of this plant showed
larvicidal activities against Aedes aegypti and rotenoids
were identified as the active principles [64]. Midowo et
al. examined the aerial exudates of Polygonum senegalense
Usararotenoid C (35):
R1 = OMe, R2 = Prenyl
Usararotenoid A (36):
R1 - R2 = -OCH2O-
(+)-Usararotenoid B (37):



















Figure 3 Promising anti-malarial retenoids from African medicinal plants.
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plasmodial activities of the first 9-hydroxyhomoisoflavo
noid (28), 2,3-dihydro-5-hydroxy-7-methoxy-2-phenyl-
chromen-4-one (29), along with the antiplasmodial ac-
tivities of some of chalconoids and a flavanone isolated
along with it from the surface exudate of Polygonum
senegalense [61].
The antiplasmodial and cytotoxic activities of flavo-
noids and arylbenzofuran derivatives from Morus meso-
zygia were investigated by Zelefack et al. [65]. This plant
is used in treating many diseases, including malaria and
fever. Fractionation of the methanolic extract of its stem
bark led to the isolation and identification of two flavo-
noids: artocarpesin (31) and kushenol E (32), among
other compounds (mulberrofuran F, bartericin A and
4-hydroxylonchocarpin). The methanolic extract and the
isolated compounds were tested for antiplasmodial activ-
ity against the chloroquine-resistant FcB1 P. falciparum
strain and cytotoxicity on MCF-7 human breast cancer
cells. It was found that all compounds were active
against the FcB1 strain of Plasmodium, with compounds
31, 32 and mulberrofuran F exhibiting particular po-
tency (with the median inhibitory concentrations IC50 =
2.5- 2.6 μg mL−1).
Isoflavones
The isoflavone dimer, mucusisoflavone C (33), derived
from the figs of Ficus mucuso, harvested near Yaoundé
in Cameroon, exhibited a weak inhibitory activity against
the validated drug target P. falciparum enoyl-ACP re-
ductase (PfENR), with an IC50 value of 7.69 μM [66].
The acetone extracts of the root bark and stem bark of
Erythrina sacleuxii showed antiplasmodial activities against
the D6 and W2 strains of P. falciparum. Further chromato-
graphic separation of the acetone extract of the root barkby Andayi et al. afforded a new isoflavone, 7-hydroxy-4′-
methoxy-3′-prenylisoflavone, named 5-deoxy-3′-prenyl-
biochanin A (34) along with known isoflavonoids as the
antiplasmodial principles [67]. Flavonoids and isoflavonoids
isolated from the stem bark of E. sacleuxii were also tested
and showed antiplasmodial activities.
Rotenoids
Milletia usaramensis ssp. usaramensis is a plant growing
in East Africa, which is reported to contain anti-malarial
flavonoids, particularly rotenoids [58]. Seven rotenoids
have been reported from this species, including usararo-
tenoid C (35), usararotenoid A (36), (+)-usararotenoid B
(37), and (+)-12a-epi-millettosin (38). These compounds
exhibited moderate to weak antiplasmodial activity
against the D6 and W2 strains of P. falciparum. Yenesew
et al. further established some structure–activity rela-
tionships. It was observed that rotenoids containing a
prenyl unit or a 2,2-dimethylpyrano substituent were
more potent than the non-prenylated rotenoid, e g,
usararotenoid A. It was also reported that there is no
significant activity for usararotenoid B, suggesting the
importance of the carbonyl function at C-12 in usararo-
tenoid A for the weak antiplasmodial activity observed.
Phenolics
Zofou et al. have isolated p-hydroxy-cinnamic acid (39),
along with other compounds, atranorin, specicoside,
2β,3β,19α-trihydroxy-urs-12-20-en-28-oic acid, from the
stem bark of Kigelia africana (Bignoniaceae), harvested
from Cameroon and performed the drug interactions of
the isolated compounds among themselves, as well as
their combination effects with quinine and artemether
[68]. The antiplasmodial activity and drug interactions
were evaluated against the multidrug-resistant W2mef
Table 2 Summary of promising anti-malarial phenolics, polyacetylenes and quinones derived from African flora
Compound class Isolated metabolites Plant species (Family) Part of plant studied Place of harvest (locality, country) Author, reference
Phenolics 39 Kigelia africana (Bignoniaceae) Stem bark Bandjoun, Cameroon Zofou et al. [68,69]
40 and 41 Sorindeia juglandifolia (Anacardiaceae) Fruits Mt. Kalla, Yaoundé, Cameroon Boyom et al. [70]
Kamkumo et al. [71]
42 Combretum molle (Combretaceae ) Stem bark Tigray region, Northern Ethiopia Asres et al. [72]
43 Alchornea cordifolia (Euphorbiaceae) Leaves Ivory Coast Banzouzi et al. [73]
44 Vepris uguenensis (Rutaceae) Roots Baringo District, Kenya Cheplogoi et al. [74]
45 Garcinia polyantha (Guttiferae) Roots Mt Kalla, Yaoundé, Cameroon Lannang et al. [75]
46 Gossypium sp. (Malvaceae) Seeds Diverse regions from the continent Deck et al. [76]
Polyacetylenes 47, 48, 49 and 50 Cussonia zimmermanii (Araliaceae) Root bark Pugu Forest, Tanzania Senn et al. [77]
Quinones 51, 52, 53 and 54 Hoslundia opposita (Lamiaceae) Root bark Tanzania Achenbach et al. [78]
55 Cassia siamea (Fabaceae) Stem bark Otu (Oyo State), Nigeria Ajaiyeoba et al. [79]
56, 57, 58, 59, 60 and 61 Psorospermum glaberrimum (Hypericaceae) Root bark Ekombité, Cameroon Lenta et al. [80]
62, 63, 64, 65 and 66 Harungana madagascariens (Hypericaceae) Root bark Bazou, Cameroon Lenta et al. [81]
67 Spathodea campanulata (Bignoniaceae) Stem bark Ibadan, Nigeria Makinde et al. [82]
68 and 69 Kniphophia foliosa (Asphodelaceae) Roots Dagne et al. [83]
Bringmann et al. [84]
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11,16-diacetoxyoctadeca-17-ene-12,14- diynyl acetate  (50)
Figure 5 Some anti-malarial/antiplasmodial polyacetylenes
from African medicinal plants.
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http://www.malariajournal.com/content/13/1/81strain of P. falciparum. The results equally showed a
slight synergistic effect between atranorin and 2β,3β,19α-
trihydroxy-urs-12-20-en-28-oic acid (combination index,
CI of 0.82) whereas the interaction between specicoside
and p-hydroxycinnamic acid was instead antagonistic
(CI of 2.67). All three compounds were shown tosignificantly act in synergy with some first line malaria
drugs like artemether (CI of 0.42 to 0.71). More ex-
citingly, none of these four compounds showed any sig-
nificant sign of toxicity against the monkey kidney cell
strains LLC-MK2 (selectivity index below 10). Com-
pound 39 exhibited antiplasmodial activitity against the
W2mef strain with an IC50 value of 2.11 μg mL
−1 [69].
The origins of the isolated anti-malarial/antiplasmodial
phenolics are shown in Table 2, while the chemical struc-
tures are shown in Figure 4.
In an effort to identify a lead compound for anti-
malarial drug discovery, Kamkumo et al. investigated the
Ntie-Kang et al. Malaria Journal 2014, 13:81 Page 9 of 20
http://www.malariajournal.com/content/13/1/81fruits of Sorindeia juglandifolia (Anacardiaceae) from
Mt Kalla in Cameroon and tested the isolated com-
pounds in vitro against the P. falciparum W2, against
field isolates of P. falciparum, and against the P. falcip-
arum recombinant cysteine protease falcipain-2 [70,71].
The main end products of the activity-guided fraction-
ation were 2,3,6-trihydroxy benzoic acid (40) and 2,3,6-
trihydroxy methyl benzoate (41). Overall, nine fractions
tested against P. falciparum W2 and falcipain-2 were ac-
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Figure 6 Anti-malarial/antiplasmodial quinones from African medicinfor W2, and 1.1-21.9 μg mL−1 for falcipain-2. Purified
compounds (40 and 41) also showed inhibitory effects
against P. falciparum W2 (IC50s 16.5 μM and 13.0 μM)
and falcipain-2 (IC50s 35.4 and 6.1 μM). In studies of P.
falciparum isolates from Cameroon, the plant fractions
demonstrated IC50 values of 0.14-19.4 μg mL
−1 and com-
pounds (40 and 41) values of 6.3 and 36.1 μM. In vivo as-
sessment of compound 40 showed activity against
Plasmodium berghei strain B, with mean parasitaemia
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Bazouanthrone (62): R1 = Prenyl, R2 = Prenyl, R3 = OH, R4 = H
Feruginin A (63): R1 = H, R2 = Prenyl, R3 = H, R4 = Prenyl
Harunganin (64): R1 = H, R2 = Prenyl, R3 = Prenyl, R4 = H
Harunganol A (65): R1 = H, R2 = H, R3 = Prenyl, R4 = Prenyl
























Coumarins 72 and 73 Vernonia brachycalyx (Asteraceae) Roots Cubukcu et al. [86]
74 Toddalia asiatica (Rutaceae) Roots Rachuonyo District, Kenya Oketch-Rabah et al.
[88]
75 Schefflera umbellifera (Araliaceae) Leaves Limpopo, South Africa Mthembu et al. [89]
Xanthones 76 and 77 Hypericum lanceolatum
(Hypericaceae)
Stem bark Mt. Bamboutos,
Cameroon
Zofou et al. [90]
78, 79, 80, 81,
82 and 83
Allanblackia monticola (Guttiferae) Stem bark Bagangté, Cameroon Azebaze et al. [91]
84, 85 and 86 Symphonia globulifera (Clusiaceae) Seeds Fundong, Cameroon Ngouela et al. [92]






















Figure 7 Coumarins from from African medicinal plants with
promising anti-malarial/antiplasmodial activities.
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http://www.malariajournal.com/content/13/1/8142.2 mg kg−1, respectively. Active fractions were found to
be safe in mice after oral administration of 7 g kg−1 body
weight. These results suggest that further investigation of
the anti-malarial activities of natural products from S.
juglandifolia will be appropriate.
The Ethiopian medicinal plant Combretum molle (Com-
bretaceae), reported to possess genuine anti-malarial activity,
was investigated by Asres et al. [72]. The fractionation of
the stem bark extract yielded punicalagin (42) as the active
compound. This compound exhibited in vitro activity
against the 3D7 strain of P. falciparum with IC50 values of
2.19 μg mL−1. Ellagic acid (43), derived from the leaves of
Alchornea cordifolia (Euphorbiaceae), showed good acti-
vity against P. berghei in mice with an ED50 in the range of
0.2-0.151 μg mL−1 [73]. Cheplogoi et al. investigated the
roots of Vepris uguenensis (Rutaceae), harvested from the
Baringo District, Kenya [74]. Syringaldehyde (44) was
identified as an active compound, exhibiting moderate
antiplasmodial activity against two strains of P. falci-
parum, with IC50 values of 13.0 μg mL
−1 (chloroquine-
susceptible 3D7 strain) and 21.4 μg mL−1 (chloroquine-
resistant FCM29 strain), respectively.
From the methanol extract of roots of Garcinia poly-
antha, Lannang et al. isolated Isoxanthochymol (45),
which exhibited in vitro anti-malarial activity against
P. falciparum and showed strong chemosuppression of
parasitic growth [75]. The compound exhibited anti-
malarial activity with an IC50 of 2.21 μM. This was lower
than the IC50 of the other five co-occurring compounds
(garcinane, smeathxanthones A and B, chefouxanthone,
isoxanthochymol, magnificol, and β-sitosterol and garci-
niaxanthone I), which ranged from 2.5 to 4.1 μM. The
compounds were administered over a period of four days
to the culture and the number of parasites was determined
daily. Control experiments were performed either without
treatment or with administration of 0.032 μM chloroquine
in the same solvent. Gossypol (46), derived from the seeds
of cotton plant (Gossypium sp., Malvaceae), exhibits a
variety of biological activities, including antispermatogenic,anti-cancer, antiparasitic and antiviral activity. Deck et al.
demonstrated that this compound also showed anti-
malarial activity against both chloroquine-sensitive and
chloroquine-resistant strains of P. falciparum, with IC50
values in the order of 10 μM [76]. The presence of alde-
hyde functional groups renders gossypol toxic and in the
light of this fact, authors further investigated synthetic ana-
logues of compound 46 for biological activity. It was found
that the synthetic analogues lost toxicity while retaining
antiplasmodial activity.
Polyacetylenes
Polyacetylenes have unique chemical structures, which
make them rare and often unstable and very reactive.
They thus have a wide variety of biochemical and
pharmacological uses. Senn et al. investigated the root
bark extract of Cussonia zimmermanii (Araliaceae) from
the Pugu Forest in Tanzania, a plant commonly used to
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http://www.malariajournal.com/content/13/1/81treat malaria, fever and epilepsy [77]. Four polyacetylenes
were isolated, namely: 8-hydroxyheptadeca-4,6- diyn-3-yl
acetate (47), 8-hydroxyheptadeca-1-ene-4,6-diyn-3-yl
acetate (48), 16-acetoxy-11-hydroxyoctadeca-17-ene-
12,14-diynyl acetate (49) and 11,16-diacetoxyoctadeca-
17-ene-12,14-diynyl acetate (50), Figure 5. Com-
pounds 47 to 49 showed high anti-malarial activity
against P. falciparum, with IC50 values of 5.9, 0.44






















































Figure 8 Xanthones from from African medicinal plants with promisinQuinones
Quinones also exhibit diverse pharmacological proper-
ties, including anti-malarial activity. Four quinones have
been isolated from the root bark of Hoslundia opposita by
Achenbach et al. [78], including 3-O-benzoylhosloppone
(51), 3-O-cinnamoylhosloppone (52), 3-O-benzoylhinokiol
(53), and 3-O-benzoylhosloquinone (54), Figure 6. The
antiplasmodial activities of compound 51 have helped to
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Figure 9 Steroids from African medicinal plants with
antiplasmodial activity.
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http://www.malariajournal.com/content/13/1/81treatment of malaria [78]. The isolation of these com-
pounds was carried out as a result of an ethnomedical use
of H. opposita in the treatment of malaria. The n-hexane
extract root bark gave an IC50 of 5.6 μg mL
−1 and also ex-
hibited a 26% inhibition of growth of P. berghei in mice, at
a daily dose of 190 mg kg−1 body weight, for four days
[78]. Only compound 51 was tested and showed signifi-
cant in vitro activity against the multidrug-resistant
K-1 strain and the chloroquine-sensitive NF54 strain
of P. falciparum, with IC50 values of 0.4 and 0.22 μg mL
−1,
respectively. The other metabolites were not screened
due to the limited amount available [78].
Cassia siamea (Fabaceae) was identified from south-
west Nigerian ethnobotany as a remedy for febrile ill-
ness. This led to the bioassay-guided fractionation of
stem bark of the plant extract, for assessing the in vitro
anti-malarial activity. Emodin (55) and lupeol were iso-
lated from the ethyl acetate fraction. Both compounds
were found to be the active principles responsible for the
antiplasmodial property with IC50 values of 5 μg mL
−1
respectively [79].
Six quinones were derived from the root bark extract
of Psorospermum glaberrimum (Hypericaceae) from
Cameroon by Lenta et al. [80]. These include glaberian-
throne (56), 3-geranyloxyemodin anthrone (57), acety-
lvismione D (58), 2-geranylemodin (59), bianthrone 1a
(60), and 3-prenyloxyemodin anthrone (61). The n-
hexane extracts and the isolated compounds were tested
in vitro for their antiplasmodial activity against P. falci-
parum (W2). The n-hexane extract showed good anti-
plasmodial activity, with IC50 of 0.87 μg mL
−1,
meanwhile 3-geranyloxyemodin anthrone and acetyl-
vismione D showed the best potencies against P. falcip-
arum W2 strain with IC50 of 1.68 μM and 0.12 μM,
(0.66 μg mL−1 and 0.054 μg mL−1), respectively. The
same authors investigated the root bark of Harungana
madagascariens (Hypericaceae), a plant whose roots and
bark are used by traditional healers to treat malaria in
West Province of Cameroon [81]. These authors isolated
bazouanthrone (62), a new anthrone derivative, along
with the known compounds, feruginin A (63), harunga-
nin (64), harunganol A (65), and harunganol B (66). In
order to validate its ethnobotanical use, the antiplasmo-
dial activity of the isolated compounds were evaluated in
culture against W2 strain of P. falciparum. All the com-
pounds were found to be active against the Plasmodium
parasites with bazouanthrone (62) showing particular
potency (IC50 = 1.80 μM).
Makinde et al. investigated the action of extracts of
the stem bark of Spathodea campanulata (Bignoniaceae)
from Nigeria on Plasmodium berghei berghei in mice
[82]. The blood schizontocidal activity of the extracts
was studied in early and established infections using
chloroquine as the reference drug. The prophylacticaction of the extracts was also investigated with pyri-
methamine as the standard drug. The hexane and
chloroform extracts of the stem bark showed blood schi-
zontocidal action in both the four-day test and Rane test.
The chloroform extract demonstrated some prophylactic
properties while the aqueous extract did not show any
significant anti-malarial property. In addition, these au-
thors were able to identify the active anti-malarial ingre-
diant to be lapachol (67). The other anti-malarial
quinones identified were knipholone (68) and anthrone
(69) from Kniphophia foliosa (Asphodelaceae) [83,84], as
well as 2-(1-hydroxyethyl)naphtho[2,3-b]furan-4,9-dione
(70) and isopinnatal (71) from Kigelia pinnata
Table 4 Summary of promising anti-malarial steroids, lignans, other antiplasmodial compounds derived from African flora
Compound sub class Isolated metabolites Plant species (Family) Part of plant studied Place of harvest (City, Country) Author, Reference
Steroids 91 Ajuga remota (Lamiaceae) Aerial parts Nairobi, Kenya Kuria et al. [94]
92, 93, 94, 95 and 96 Vernonia amygdalina (Asteraceae) Young pith of trees Mahale Mt. National Park,
Tanzania
Ohigashi et al. [95]
Lignanes 97, 98, 99, 100, 101, 102 and 103 Pycnanthus angolensis (Myristicaceae) Stem bark São Tomé and Príncipe islands Ramalhete et al. [96]
104 Asparagus africanus (Asparagaceae) Roots Kenya Oketch-Rabah et al.
[97]
Others 105 Lippia javanica (Verbenaceae) Leaves and stalks Limpopo, South Africa Ludere et al. [98]
106 Helichrysum cymosum (Asteraceae) Whole plant South Africa Jakupovic et al. [99]
Vuuren et al. [100]
107, 108, 109 and 110 Vernonia staehelinoides (Asteraceae) Leaves Magaliesburg, South Africa Pillay et al. [101]
111 Hypericum lanceolatum (Hypericaceae) Stem bark Mt. Bamboutos, Cameroon Zofou et al. [90]
112 Symphonia globulifera (Clusiaceae) Seeds Fundong, Cameroon Ngouela et al. [92]
113 Morus mesozygia (Moraceae) Stem bark Centre Province, Cameroon Zelefack et al. [61]
114 and 115 Kigelia africana (Bignoniaceae) Stem bark Bandjoun, Cameroon Zofou et al. [64,65]
116 and 117 Glossocalyx brevipes (Monimiaceae) Leaves Kumba, Cameroon Mbah et al. [102]
118 Asparagus africanus (Asparagaceae) Roots Kenya Oketch-Rabah et al.
[97]
119 Dracaena mannii and Dracaena arborea
(Dracaenaceae)
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Figure 10 Lignans from African medicinal plants with
promising anti-malarial/antiplasmodial activities.
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http://www.malariajournal.com/content/13/1/81(Bignoniaceae) [85]. These compounds were tested
against chloroquine-sensitive (T9 − 96) and -resistant
(K-1) P. falciparum strains and for cytotoxicity using KB
cells. Compound 70 possessed good activity against both
strains [IC50 values 627 nM (K1), 718 nM (T9 − 96)]. Iso-
pinnatal (71) and the co-occurring kigelinol and isokige-
linol exhibited lower activity against both strains.
Bringmann et al. also reported that knipholone (68) and
three of its natural derivatives from the same plant, as
well as seven structurally related but simplified com-
pounds, have been examined for their antiplasmodial ac-
tivity against asexual erythrocytic stages of two strains of
P. falciparum in vitro (K1/chloroquine-resistant and NF
54/chloroquine-sensitive) [84]. All the phenylanthraqui-
nones showed considerable activity, with only little cyto-
toxicity, while their anthraquinone and phenyl moieties
were completely inactive.
Coumarins
Anti-malarial coumarins have been identified by Cubukcu
et al. [86] and by Noster et al. [87] from Vernonia brachy-
calyx (Asteraceae) and Toddalia asiatica (Rutaceae),
respectively. Cubukcu et al. identified two isomeric
5-methylcoumarins from the roots of V. brachycalyx; 20-
epi-cycloisobrachycoumarinone epoxide (72) and cycloiso-
brachycoumarinone epoxide (73), Table 3 and Figure 7.
The results of the antiplasmodial assays against the
chloroquine-susceptible 3D7 and chloroquine- resistant
Dd2 strains of P. falciparum, showed that compound 72
was weakly active, with IC50 values of 160 μM and 54 μM,
while for compound 73, the IC50 values were 111 μM and
54 μM, respectively. Noster et al. also isolated compound
73 from the ether extract of Exostema caribaeum but
however only moderate activity [87]. In addition, Oketch-
Rabah et al. isolated a new anti-malarial coumarin,
5,7-dimethoxy-8-(30-hydroxy-30-methyl- 10-butene) cou-
marin (74), from the roots of Toddalia asiatica [87].
This compound showed moderate activity against the
chloroquine-sensitive K39 and chloroquine-resistant V1/S
strains of P. falciparum strains, with IC50 values of
16.2 μg mL−1 and 8.8 μg mL−1, respectively.
The anti-malarial coumarin 7-hydroxy6-methoxycou-
marin or scopoletin (75) was isolated from the dichloro-
methane leaf extract of Schefflera umbellifera (Araliaceae),
harvested from Limpopo, South Africa by Mthembu et al.
[89]. This compound was evaluated in vitro against
both the chloroquine-susceptible (D10) and chloroquine-
resistant (K-1) strains of P. falciparum for anti-malarial
activity, with an IC50 value of 28.2 μg mL
−1.
Xanthones
The anti-malarial xanthones; 5-hydroxy-3- methoxyx-
anthone (76) and 3-hydroxy-5-methoxyxanthone (77)
were isolated from stem bark of Hypericum lanceolatum(Hypericaceae) from Cameroon by Zofou et al. [90],
with IC50 values of 13.56 μg mL
−1, and 8.28 μg mL−1,
respectively, on the multidrug-resistant W2mef strain of
P. falciparum. Six other anti-malarial xanthones were
isolated from the methanol extract of the stem bark of
Allanblackia monticola (Guttiferae) from Cameroon, by
Azebaze et al. [91]. These included allanxanthone C (78),
garciniafuran (79), tovophyllin A (80), rubraxanthone
(81), norcowanin (82) and mangostin (83), Figure 8.
Allanxanthone C exhibited an IC50 of 1.3 μM on FcM29
and an IC50 of 6.9 μM on F32. The molecules with inter-
esting activities are known to be norcowanin (IC50 of
6.3 μM on F32) and mangostin (IC50 of 4.1 μM on FcM29
and IC50 of 7.8 μM on F32 [91]. More interestingly, these
molecules showed no significant toxicity against the hu-
man melanoma cell A375 cell-line. The antiplasmodial
activities of xanthones isolated from the seed shells of
Symphonia globulifera were reported against the W2
Plasmodium sp. with respective IC50 values of 3.53, 1.29
and 3.17 μM, for gaboxanthone (84), symphonin (85)
and globuliferin (86) [92]. Bioassay-guided fractionation
of the fruit pericarp of Pentadesma butyracea, using the
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xanthone, named pentadexanthone (87) (IC50 = 3 μM
against W2), together with three known compounds:
cratoxylone (88) (IC50 = 2.89 μM), α-mangostin (89) (IC50 =
2.77 μM), and garcinone E (90) (IC50 = 0.41 μM) [93].Steroids
The steroid, ergosterol-5,8-endoperoxide (91), isolated
from the aerial parts of Ajuga remota, exhibited high
antiplasmodial activity against the chloroquine-sensitive
FCA 20/GHA strain of P. falciparum, with an IC50 value
of 8.2 μM [94]. Steroidal saponins with anti-malarial ac-
tivity have also been isolated from the leaves of Vernonia
amygdalina [95]. Ohigashi et al. reported the isolation
of vernonioside A1 (92), A2 (93), A3 (94), A4 (95) and
B1 (96), Figure 9 and Table 4. These saponins had weak
antiplasmodial activity against the multidrug-resistant
K-1 strain of P. falciparum, with IC50 values of 139.7,
94.1, 245.1, 81.8 and 46.1 μg mL−1, respectively [95].
These saponins are also reported to be the bitter com-
pounds in the leaves of V. amygdalina.Lignans
Pycnanthus angolensis (Myristicaceae) is a plant used in
traditional medicine against several diseases. Its bark has
been used to treat fever and malaria in São Tomé and
Príncipe islands. Ramalhete et al. submitted the dich-
loromethane extract of the bark to anti-malarial screen-
ing and observed an activity against 3D7 P. falciparum
strain (IC50 = 1.6 μg mL
−1) [96]. This was further sub-
jected to chromatographic bioguided fractionation, yield-
ing the lignans 4,4′-dihydroxy-3-methoxylignan (97),
(−)-dihydroguaiaretic acid (98), 4′-hydroxy-3,3′,4-tri-
methoxylignan (99), 4,4′-diacetyl-3,3′-dimethoxylignan
(100), talaumidin (101), hinokinin (102), and helio-
buphthalmin (103), Figure 10, along with the labdane
diterpene ozic acid and the steroids stigmast-4-en-6β-ol-
3-one, stigmasterol and β-sitosterol. Furthermore, other
compounds were obtained by derivatization. The in vitro
anti-malarial activity of the compounds was evaluated
against 3D7 and Dd2 P. falciparum strains. The best
in vitro activities were exhibited by compound 97 against
the 3D7 strain (IC50 = 31.0 μg mL
−1) and by compound
101 against the Dd2 strain (IC50 = 20.7 μg mL
−1).
Asparagus africanus (Asparagaceae) is used by the
Akamba tribe in Kenya to treat malaria. A bioassay-
guided fractionation of the root extract led to the isola-
tion of the lignan nyasol (104), along with the sapogenin
muzanzagenin (119), Figure 11, as the bioactive com-
pounds responsible for the anti-malarial activity of this
plant [97]. Nyasol moderately inhibited P. falciparum
schizonts with the IC50 of 49 μM, while muzanzagenin
showed a moderate in vitro activity against four differentmalaria schizont strains the IC50 values were 16, 163, 23,
and 16 μM, respectively.
Others
Lippialactone (105), derived from the ethyl acetate extract
of aerial parts of Lippia javanicais, harvested from South
Africa, was shown to be active against the chloroquine-
sensitive D10 strain of P. falciparum with an IC50 value of
9.1 μg mL−1, and is also mildly cytotoxic [98]. Helihumu-
lone (106) was derived from extracts of the whole plant of
Helichrysum cymosum (Asteraceae) from South Africa by
Jakupovic et al. [99] and Vuuren et al. [100].
The dichloromethane extract of the leaves of Vernonia
staehelinoides (Asteraceae) showed in vitro activity (IC50
~ 3 μg mL-1) against the chloroquine-sensitive D10 and
the chloroquine-resistant (K-1) strains of P. falciparum
[101]. Pillay et al. further investigated the extract by
bioassay-guided fractionation and two structurally re-
lated hirsutinolides displaying in vitro antiplasmodial ac-
tivity (IC50 ~ 0.2 μg mL
−1 against D10) were isolated.
These were 8α-(2- methylacryloyloxy)-3-oxo-1-desoxy-
1,2-dehydrohirsutinolide-13-O-acetate (107), and 8α-
(5′-acetoxysenecioyloxy)-3-oxo-1-desoxy-1,2-dehydro-
hirsutinolide-13-O-acetate (108). These were found to
be cytotoxic to mammalian Chinese hamster ovarian
(CHO) cells at similar concentrations, but proved to be
attractive scaffolds for structure-activity relationship
studies. Two main privileged substructures, a 2(5H)-
furanone unit and a dihydrofuran-4- one unit, were
identified as potential pharmacophores, which may be
responsible for the observed biological activity. Muco-
chloric and mucobromic acids were selected as appro-
priate 2(5H)-furanone substructures and these were
shown to have comparable activity against the D10 and
superior activity against the K1 strains relative to the
hirsutinolide natural product. Mucochloric and muco-
bromic acids (109 and 110) also showed selective
cytotoxicity to the malaria parasites compared to mam-
malian (CHO) cells in vitro. The antiplasmodial data ob-
tained with respect to these two acids suggest that the 2
(5H)- furanone substructure is a key pharmacophore in
the observed antiplasmodial activity. The identification of
antiplasmodial hirsutinolides from V. staehelinoides sug-
gests that they may play a role in the medicinal properties
of the plant, but their potential for the development of
anti-malarial drugs is limited due to inherent cytotoxicity
and lack of selectivity. The results did however lead to the
identification of potential pharmacophores, a 2(5H)-fura-
none unit and a dihydrofuran-4-one unit.
The benzophenone 2,5,2′,6′-tetrahydroxybenzophenone
(111), from the stem bark of Hypericum lanceolatum
(Hypericaceae), exhibited an interesting activity against the
multidrug-resistant strain W2mef, with an IC50 of
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Figure 11 Other metabolites from African medicinal plants with promising anti-malarial/antiplasmodial activities.
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http://www.malariajournal.com/content/13/1/81(112) from the seeds of Symphonia globulifera (Clusiaceae)
[92]. This compound exhibited activity against the W2
Plasmodium sp. with IC50 of 3.17 μM. Mulberrofuran F
(113), from the stem bark of Morus mesozygia (Moraceae),
was active against FcB1-Columbia strain, considered
to be resistant against chloroquine, with IC50 of
2.6 μg mL−1 [65]. Atranorin (114) and specicoside
(115), derived from the stem bark extract of Kigelia
africana (Bignoniaceae) [68,69], were both active
against the multidrug-resistant W2mef strain of P. fal-
ciparum with respective IC50 values of 0.67 μg mL
−1
and 0.52 μg mL−1.The homogentisic acid derivatives methyl 2-(1′β-gera-
nyl-5′β-hydroxy-2′- oxocyclohex-3′-enyl) acetate (116)
and 2-(1′β-geranyl-5′β-hydroxy-2′- oxocyclohex-3′-
enyl) acetic acid (117) were isolated by Mbah et al. from
the leaves of Glossocalyx brevipes (Monimiaceae) [102].
Compounds 116 and 117 exhibited both anti-malarial
[102] and antisalmonellal activities [104]. The sapogenin
muzanzagenin (118) and the saponin spiroconazole A
(119), respectively isolated from Asparagus africanus
(Asparagaceae) [97] and from the West Africa ‘soap tree’
Dracaena sp. (Dracaenaceae) [103], also demonstrated
significant anti-malarial activities. Spiroconazole A is
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malarial and molluscicidal activities.
Conclusions
In this review, an attempt has been made to summarise
the main finding of several research groups engaged in
the search for naturally occurring active principles from
African medicinal plants against P. falciparum. With
multiple resistance developed by the malaria parasite,
the cry has been towards obtaining new effective drugs.
Attempts to develop ‘green pharmacies’ for improved
phytomedicines against malaria are being encouraged by
some NGOs and governments as part of their efforts to
control malaria [105]. Additionally, modern hit/lead dis-
covery efforts for specific anti-malarial drug targets are
being encouraged. The trend has been towards accelerat-
ing this process by employing computer-based methods
such as docking, virtual screening, pharmacophore mod-
elling and binding-free energy calculations for hit/lead
identification and combinatorial design of novel inhibi-
tors against known anti-malarial drug targets. The prac-
tice of virtual screening is beginning to occupy the
centre of drug discovery efforts [106] and it has been
verified that developing NP libraries containing readily
available compounds for screening virtual hits could be
highly useful [107]. The authors of this paper have been
developing NP databases containing three-dimensional
structures of compounds derived from plants used in
ATM [108-110] and using computed molecular descrip-
tors to attempt to predict the pharmacokinetic profiles
of NPs [110-112]. Since the role of NPs in drug disco-
very cannot be overemphasized [111-116], efforts are
aimed at providing tools for research groups engaged in
anti-malarial drug discovery, beginning with NPs derived
from African medicinal plants. This is aimed at cutting
down the cost of drug discovery when computational
and ‘wet lab’ approaches are combined [117,118]. The
intention is to make the current collection of three-
dimensional structures of naturally occurring anti-
malarials from African medicinal plants available for
virtual screening. This shall be the scope of part III of
this series.
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